Alkem Imperia Online Quiz - June'2018

1. Dabiclot reduces the risk of first stroke or systemic embolism over warfarin by:

20%

25%

30%

35%

2. What is MUPS technology?

Multiple Particulate technology

Multi Unit Particulate System technology

Multi Para System technology

None of the above

3. What are the competitors of Dabiclot?

Pradaxa

Dabistar

Dabigat

All options are true

4. What is the quantity of Business Desk Lamp received per ME?

20

40

30

10

5. Which competitor brand will you focus on for conversion to Muzika?

Isolazine

Isoflav

Isodac

Isoniazid

6. RELYABLE trial was an extension of RELY trail for how many years:

4 years

6 years

2.3 years

1 year

7. Ezuric/Muzika is being promoted to how many doctors?

5

10

15

20

8. Dose of Dabiclot in patients with creatinine clearance 15-30ml/min will be:

150mg BID

110mg BID

75mg BID

Not recommended

9. Dabiclot 110mg reduces risk of intracranial bleeding over Warfarin by what percent:

69%

65%

60%

55%

10. What is HPMC?

Hydroxy Pentyl Mono Cellulose

Hydroxy Propyl Methyl Cellulose

Hydro Propane Methane Cellulose

None of the above

11. What is the quantity of JAPI reprints received per ME?

20

40

30

60

12. Ezuric is indicated in which class of patients:

NYHA Class I

NYHA Class II

NYHA Class III

NYHA Class II – IV

13. The special input (Business desk Lamp) will be given on priority to which set of drs:

RM/DSM adopted drs

20 drs selected for effort driven conversion for Dabiclot

10 drs selected for Ezuric/Muzika

Any dr out of 60

14. Why will a dr prefer Dabiclot over other brands of Dabigatran

Innovative manufacturing process to overcome technical challenges

HPMC capsule shell

Bioequivalence study compared with US Innovator

All of the above

15. Muzika is indicated in which class of patients:

NYHA Class I

NYHA Class II

NYHA Class III

NYHA Class III – IV

16. Clot Case Series Issue 6 talks about which of the following topics:

Use of Dabigatran in patient not responding to Warfarin

Use of Dabigatran in a non anti coagulated patient determined on basis of CHADSVASc Score

Use of Dabigatran in patient with AF on antiplatelet therapy

None of the above

17. In case of the Drs being targeted for Ezuric and Muzika, which brand will be promoted first?

Dabiclot

Ezuric

Muzika

Any of the above

18. Chemist availability for Ezuric/Muzika is to be done at how many retailers?

10

20

30

40

19. Dabiclot brand reminder input for the month of May was:

Dabiclot paper weight

Dabiclot Chit pad

Dabiclot Rx pad

None of the above

20. Which competitor brand(s) will you focus on for conversion to Ezuric?

Isodac

Eptus

Planep

Both b & c are true